Evolve BioSystems company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Founded Year



Series D | Alive

Total Raised


Last Raised

$65M | 1 yr ago

About Evolve BioSystems

Evolve BioSystems develops products to establish, restore, and maintain a healthy human microbiome across a range of unmet clinical needs. Evolve's discovery platform is now being applied to solving dysbiosis issues throughout the human life cycle as well as in similar problems in production animal species.

Evolve BioSystems Headquarter Location

2121 2nd St. Suite C108

Davis, California, 95618,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Evolve BioSystems

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Evolve BioSystems is included in 2 Expert Collections, including Omics.



275 items


Biopharma Tech

838 items

Evolve BioSystems Patents

Evolve BioSystems has filed 18 patents.

The 3 most popular patent topics include:

  • Bacteriology
  • Microbiology
  • Digestive system
patents chart

Application Date

Grant Date


Related Topics




Bacteriology, Probiotics, Digestive system, Enterobacteriaceae, Lactobacillaceae


Application Date


Grant Date



Related Topics

Bacteriology, Probiotics, Digestive system, Enterobacteriaceae, Lactobacillaceae



Latest Evolve BioSystems News

Probiotics Market to Reach USD 94.48 Billion by 2020-2027 | Probiotics Industry Exhibit CAGR of 7.9%

Feb 23, 2022

Evolve Biosystems, Inc. (Davis, California) Probiotics are healthy yeasts and bacteria that aid in the overall development of the digestive system that keep the gut healthy. Some of these extensively adopted supplements are Bifidobacterium, Lactobacillus, and Saccharomyces which enable several health benefits when consumed regularly. Apart from the enhanced gut, they aid in reducing depression and promote healthy heart functioning amongst the consumer. They are generally added to food products such as yogurt and are considered as an immunity-boosting product across the globe. The market report includes a detailed assessment of various growth drivers and restraints, opportunities, and challenges that the market will face during the projected horizon. Additionally, the report provides comprehensive research into the regional developments of the market, affecting its growth during the forecast period. It includes information sourced from the advice of expert professionals from the industry by our research analysts using several methodologies. The competitive landscape offers further detailed insights into strategies such as product launches, partnerships, mergers and acquisitions, and collaborations adopted by the companies to maintain market stronghold between 2020 and 2027. DRIVING FACTORS Increasing Consumption of Immunity Boosting Food Products to Spur Demand The increasing prevalence of lifestyle diseases such as obesity and diabetes is driving the demand for a healthy and balanced diet. According to the World Health Organization (WHO), the global rate of obesity amongst people has tripled since 1975. This alarming pace at which lifestyle diseases are increasing is propelling the demand for immunity-boosting products such as probiotics across the globe. Additionally, the growing adoption of technology is enabling the manufacturers to educate the consumers about the health benefits of consuming such a diet. These initiatives are further expected to boost the growth of the global probiotic bacteria market during the forecast period. Browse Detailed Summary of Research Report with TOC: Supermarkets/Hypermarkets Segment Held a 61.33% Market Share in 2019 The supermarkets/hypermarket segment held a market share of about 61.33% in 2019 and is expected to experience a considerable growth owing to the wide availability of the products and easy accessibility, along with offering several discounts, and cashback. REGIONAL INSIGHTS Asia-Pacific to Remain at the Forefront; Increasing Consumption of Fermented Drinks to Aid Growth Among all the regions, Asia-Pacific is expected to showcase an exponential growth and hold the highest position in the global probiotic bacteria market. This dominance is attributable to the increasing consumption of fermented food products that impart a healthy gut and balanced overall diet. The market in North America stood at USD 8.30 billion in 2019 and is anticipated to showcase a significant growth during the forecast period. This is ascribable to factors such as the increasing prevalence of lifestyle diseases and the presence of established manufacturers that are focusing on developing innovative products in the region between 2020 and 2027. COMPETITIVE LANDSCAPE Major Companies Focus on Introducing Innovative Products to Strengthen Their Market Positions The global probiotics market is fragmented into several major companies that are striving to maintain their presence by introducing new probiotics products to cater to the increasing demand and consolidate their position. The adoption of strategies such as partnership, collaboration, and merger and acquisition by key players to expand their distribution network will favor market growth in the forthcoming years. Get a Customized PDF: Key Industry Development: June 2020 – Pendulum Therapeutics announced the launch of Pendulum Glucose Control, the first-ever medical probiotic that is proven to lower blood sugar spike and A1C. Have a Look at Related Research Insights: Dietary Supplements Market Size, Share & COVID-19 Impact Analysis, By Type (Vitamins, Minerals, Enzymes, Fatty Acids, Proteins, and Others), Form (Tablets, Capsules, Liquids, and Powders), and Regional Forecasts, 2020 – 2027 Nutraceuticals Market Size, Share & COVID-19 Impact Analysis, By Product Type (Dietary Supplements, Functional Foods, and Functional Beverages), Distribution Channel (Hypermarkets/Supermarkets, Convenience Stores, Online Retail, and Others) and Regional Forecast, 2021-2028 About Us: Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in. Address: Mahalunge Road, Baner, Pune-411045,

Evolve BioSystems Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Evolve BioSystems Rank

  • When was Evolve BioSystems founded?

    Evolve BioSystems was founded in 2012.

  • Where is Evolve BioSystems's headquarters?

    Evolve BioSystems's headquarters is located at 2121 2nd St., Davis.

  • What is Evolve BioSystems's latest funding round?

    Evolve BioSystems's latest funding round is Series D.

  • How much did Evolve BioSystems raise?

    Evolve BioSystems raised a total of $134.68M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.